BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 23429337)

  • 21. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
    Pyo G; Elble RJ; Ala T; Markwell SJ
    Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan.
    Wei YC; Chen CK; Lin C; Chen PY; Hsu PC; Lin CP; Shyu YC; Huang WY
    Dement Geriatr Cogn Disord; 2022; 51(4):365-376. PubMed ID: 35820405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remote neuropsychological assessment of elderly Japanese population using the Alzheimer's Disease Assessment Scale: A validation study.
    Yoshida K; Yamaoka Y; Eguchi Y; Sato D; Iiboshi K; Kishimoto M; Mimura M; Kishimoto T
    J Telemed Telecare; 2020; 26(7-8):482-487. PubMed ID: 31068063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability and concurrent validity of Alzheimer's disease assessment scale - Cognitive subscale, Chinese version (ADAS-Cog-C) among Chinese community-dwelling older people population.
    Jiang Y; Yang H; Zhao J; Wu Y; Zhou X; Cheng Z
    Clin Neuropsychol; 2020 Dec; 34(sup1):43-53. PubMed ID: 32279575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.
    Chu LW; Chiu KC; Hui SL; Yu GK; Tsui WJ; Lee PW
    Ann Acad Med Singap; 2000 Jul; 29(4):474-85. PubMed ID: 11056778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
    Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Alzheimer's Disease Assessment Scale: findings from a low-education population.
    Liu HC; Teng EL; Chuang YY; Lin KN; Fuh JL; Wang PN
    Dement Geriatr Cogn Disord; 2002; 13(1):21-6. PubMed ID: 11731711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)--validation of the Slovak version.
    Kolibas E; Korinkova V; Novotny V; Vajdickova K; Hunakova D
    Bratisl Lek Listy; 2000; 101(11):598-602. PubMed ID: 11218956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
    Wessels AM; Dowsett SA; Sims JR
    J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examining the reliability of ADAS-Cog change scores.
    Grochowalski JH; Liu Y; Siedlecki KL
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.
    Park SH; Han KS
    Curr Alzheimer Res; 2022; 19(3):202-211. PubMed ID: 35379127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TE4D-Cog: a new test for detecting early dementia in English-speaking populations.
    Mahoney R; Johnston K; Katona C; Maxmin K; Livingston G
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1172-9. PubMed ID: 16315149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
    Hannesdóttir K; Snaedal J
    Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II)].
    Peña-Casanova J; Aguilar M; Santacruz P; Bertran-Serra I; Hernández G; Sol JM; Pujol A; Blesa R
    Neurologia; 1997 Feb; 12(2):69-77. PubMed ID: 9147454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
    Buschert VC; Friese U; Teipel SJ; Schneider P; Merensky W; Rujescu D; Möller HJ; Hampel H; Buerger K
    J Alzheimers Dis; 2011; 25(4):679-94. PubMed ID: 21483095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.